Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7

Journal: Science Translational Medicine

Published: 2018-10-31

DOI: 10.1126/scitranslmed.aap8677

Affiliations: 9

Authors: 14

Go to article
Institutions FC
Ionis Pharmaceuticals, Inc., United States of America (USA) 0.43
Department of Pediatrics, UC San Diego, United States of America (USA) 0.16
NIH National Eye Institute (NEI), United States of America (USA) 0.14
Duke Department of Neurology, United States of America (USA) 0.09
Shiley Eye Institute, UC San Diego, United States of America (USA) 0.07
Department of Neurology, UW, United States of America (USA) 0.07
Duke Department of Neurobiology, United States of America (USA) 0.01
Duke Department of Cell Biology, United States of America (USA) 0.01
Duke School of Medicine, United States of America (USA) 0.01

Return